- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
Bajaj Healthcare reports Q3 revenue of ₹161.22 Cr, PAT ₹15.67 Cr. Nine-month revenue hit ₹457.97 Cr, PAT ₹38.62 Cr. Board approved re-appointing key directors for three-year terms. Acquisition of Genrx Pharma for ₹10.85 Cr is pending NCLT approval.